All Stories

Samsung backs Alzheimer's blood test developer C2N Diagnostics with $10M

Samsung backed the Alzheimer’s disease blood test developer C2N Diagnostics, with $10 million to help scale up its commercial work and R&D pipeline.

Mar 13, 2025 - 23:23
 0
Samsung backs Alzheimer's blood test developer C2N Diagnostics with $10M
Samsung backed the Alzheimer’s disease blood test developer C2N Diagnostics, with $10 million to help scale up its commercial work and R&D pipeline.
Read More

Tags:

Previous Article

George Church spinout GRObio explores strategic alternatives 6 months after $60M...

Next Article

‘I don't feel we lost momentum’: Takeda’s oncology execs sharpen focus after res...

Related Posts

ImmunoPrecise teases $10M ADC, bispecific collab with major biotech

ImmunoPrecise teases $10M ADC, bispecific collab with m...

Mar 13, 2025  0

UPDATE: Biohaven's bipolar candidate fails to improve mania in pivotal trial

UPDATE: Biohaven's bipolar candidate fails to improve m...

Mar 4, 2025  0

Roche rolls out new DNA 'sequencing-by-expansion' approach

Roche rolls out new DNA 'sequencing-by-expansion' approach

Feb 21, 2025  0